isocarboxazid has been researched along with Asialia in 1 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Isocarboxazid appears to be an underutilized and potentially valuable agent for the treatment of depressed patients." | 2.65 | Side effects of isocarboxazid. ( Zisook, S, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zisook, S | 1 |
1 trial available for isocarboxazid and Asialia
| Article | Year |
|---|---|
Side effects of isocarboxazid.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Pressure; Clinical Trials as Topic; | 1984 |